Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma

EGFRvIII targeted chimeric antigen receptor T (CAR-T) cell therapy has recently been reported for treating glioblastomas (GBMs); however, physiology-based MRI parameters have not been evaluated in this setting. Ten patients underwent multiparametric MRI at baseline, 1, 2 and 3 months after CAR-T the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Sumei, O’Rourke, Donald M., Chawla, Sanjeev, Verma, Gaurav, Nasrallah, MacLean P., Morrissette, Jennifer J. D., Plesa, Gabriela, June, Carl H., Brem, Steven, Maloney, Eileen, Desai, Arati, Wolf, Ronald L., Poptani, Harish, Mohan, Suyash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325110/
https://www.ncbi.nlm.nih.gov/pubmed/30478409
http://dx.doi.org/10.1038/s41416-018-0342-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325110/
https://www.ncbi.nlm.nih.gov/pubmed/30478409
http://dx.doi.org/10.1038/s41416-018-0342-0

Ejemplares similares